Adriano Massimiliano Priola

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

Paola Sperone, Annamaria Ferrero, Fulvia Daffara et al. · Endocrine Related Cancer · 2010 · 162 citations · Full text

Advanced Acc Progressing, Second-/third-line Chemotherapy, Adrenocortical Carcinoma +13

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

Alfredo Berruti, Paola Sperone, Annamaria Ferrero et al. · European Journal of Endocrinology · 2011 · 134 citations

Differentiation of Rebound and Lymphoid Thymic Hyperplasia from Anterior Mediastinal Tumors with Dual-Echo Chemical-Shift MR Imaging in Adulthood: Reliability of the Chemical-Shift Ratio and Signal Intensity Index

Adriano Massimiliano Priola, Sandro Massimo Priola, Giovannino Ciccone et al. · Radiology · 2014 · 98 citations

Accuracy of CT-guided transthoracic needle biopsy of lung lesions: Factors affecting diagnostic yield

Adriano Massimiliano Priola, Sandro Massimo Priola, Aldo Cataldi et al. · La radiologia medica · 2007 · 90 citations · Full text

Computed Tomography, Medical Imaging, Multiple Pulmonary Nodule +12

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study

Alfredo Berruti, Nicola Fazio, Annamaria Ferrero et al. · BMC Cancer · 2014 · 86 citations · Full text